Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer

Abstract

Objective: Evaluate the prognostic value of neutrophil-lymphocyte ratio (NMR), platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) in patients with non-endometrioid endometrial cancer. Method: Laboratory and clinicopathological data from 118 patients with non-endometrioid endometrial cancer who underwent surgical resection between January 2010 and December 2019 were reviewed. NLR, PLR and MLR were analyzed for correlations with recurrence and survival. The receiver operating characteristic (ROC) curves were generated for the NLR, PLR, and MLR. Optimal cut-off values were determined as the points at which the Youden index (sensitivity + specificity -1) was maximal. Based on the results of the ROC curve analysis, the patients were grouped into high MLR and low MLR groups. Recurrence rate, disease-free survival, and overall survival were compared between the two groups. The prognostic factors were investigated using univariate and multivariate Cox proportional hazards model. Results: The optimal cut-off value of MLR was 0.191 (AUC, 0.718; p < 0.001). Significantly more patients in the high MLR group experienced recurrence (60.3% vs. 15.6%, p < 0.0001) and cancer-related deaths (46.6% vs. 13.3%, p = 0.003). In multivariate analysis, advanced stage and high MLR were independent prognostic factors for disease-free survival and overall survival. Conclusion: Elevated MLR was significantly associated poor clinical outcomes in patients with non endometrioid endometrial cancer. Our findings suggest that MLR may be clinically reliable and useful as an independent prognostic marker for patients with non-endometrioid endometrial cancer.

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer

“…Conversely, the association between clinical T stage and prognosis for PSCC remains unclear. Moses et al reported 5-year CSS rates for pTis, pT1, pT2, and pT3/4 of 100%, 84%, 54%, and 54%, respectively [ 23 ]. Based on the National Cancer Database, local excision (39%) and partial penectomy (38%) were most commonly performed for patients with PSCC [ 24 ].…”

“…Previous studies reported that several factors for PSCC patients with ILNM, including the number of positive LN, the tumor grade of the involved nodes, the LNR, and the LN diameter, were histologically associated with PLNM [ 21 , 22 ]. According to CSS, PLNM (HR 2,07; p = 0.007) and bilateral LNM (HR 2.37; p < 0.001) were independent prognostic factors in the multivariate analysis, although PLND, bilateral LNM, ≥3 positive ILNM, and the LNM diameter were associated with CSS [ 23 ]. Zhao et al reported that the LNM size, particularly >2 cm, was an independent predictor with an objective response rate and oncological outcomes in patients with esophageal SCC who did not undergo surgical treatments [ 27 ].…”

The Role of Inflammatory Markers and the Modified Systemic Inflammatory Score in Bethesda Category 3 And 4 Patients for Prediction of Malignancy

“…The idea of to diagnose cancer through simple routine laboratory tests with a little amount of blood samples is worthy of investigation for many researchers. Some inflammatory markers including lymphocyte to monocyte ratio, neutrophil to lymphocyte ratio, albumin to globulin ratio were described previously , however, majority of these studies aimed to evaluate only the prognostic significant of the aforementioned markers in different cancer types (Stotz et al, 2014;Jia et al, 2015;Gu et al, 2016;Hsueh et al, 2017;Tan et al, 2018;Song et al, 2021;Tezuka et al, 2021;Atsumi et al, 2021;Castineiras et al, 2021;Mariani et al, 2022). There were a only a few studies had been published about association between systemic inflammatory markers and prediction of cancer diagnosis (Kocer et al, 2015;Li et al, 2017;Ataş et al, 2021) .…”

The Neutrophil-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios Are Independently Associated With the Severity of Autoimmune Encephalitis

“…The monocyte-to-lymphocyte ratio (MLR) is a new inflammatory marker similar to NLR discovered in recent years. A Korean study on endometrial cancer displayed that high levels of MLR are prominently associated with cancer recurrence and cancer-related death (14). Interestingly, it has also been found to be associated with the severity and activity of some immune-related diseases such as multiple sclerosis, systemic lupus erythematosus, axial spondyloarthritis and ulcerative colitis (15)(16)(17)(18).…”